Search Results
Luciano Costa: CC-93269 Shows Clinical Activity in Previously Treated Myeloma
B-Cell Maturation Antigen (BCMA) 2+1 T Cell Engager CC-93269 in Patients with RR Multiple Myeloma
Dr. Michael Chu on CC-93269, a bispecific T-cell engager (BiTE) targeting BCMA and CD3, shows...
2019 Multiple Myeloma Symposium | Novel and Next Generation Therapy
What the African American Community Needs to Know about Multiple Myeloma
Updates on German clinical trials in multiple myeloma
How Can We Change the Course of Myeloma in the African American Community?
Learning More About Genomics and Why It Matters to African American Myeloma Patients with Dr. Morgan
How to treat a previously treated CLL patient
Better Myeloma Care in the African American Community: Dr. Joe Mikhael Interviews Dr. Brandon Blue
Dr. Ghia on ASCEND Trial Results for Previously Treated CLL
The Current Therapeutic Landscape for Relapsed or Refractory MM (pt 4 of 5 - IMF ASH 2019 Satellite)
